"iDoctor – Medical Blog"

Publication year: 2009<br><b>Source:</b> The American Journal of Cardiology, In Press, Corrected Proof, Available online 26 September 2009<br>Cheol Whan, Lee , Duk-Woo, Park , Seung-Hwan, Lee , Young-Hak, Kim , Myeong-Ki, Hong , …<br><br>Drug-eluting stents (DESs) are increasingly used for treatment of acute ST-segment elevation myocardial infarction (STEMI), but there are few comparisons of outcomes of various types of DES. We compared the efficacy and safety of zotarolimus-eluting stents (ZESs), sirolimus-eluting stents (SESs), and paclitaxel-eluting stents (PESs) in primary intervention for STEMI. This multicenter, prospectively randomized ZEST-AMI trial included 328 patients at 12 medical centers who were randomly assig

This entry was posted on Tuesday, September 29th, 2009 at 3:14 am and is filed under Health news. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.